In Vitro Evaluation of Anti-Inflammatory and Anti-Diabetic Potential Effects of Euphorbia Tithymaloides Ethanol Extract

Theresia Galuh Wandita; Najuma Joshi; Joseph Flores dela Cruz; Seong Gu Hwang

doi:10.14499/indonesianjpharm29iss1pp1

In Vitro Evaluation of Anti-Inflammatory and Anti-Diabetic Potential Effects of Euphorbia Tithymaloides Ethanol Extract

Theresia Galuh Wandita, Najuma Joshi, Joseph Flores dela Cruz, Seong Gu Hwang

Abstract

This research work aims to develop glipizide tablets using Hibiscus rosasinensis leaves mucilage. The mucilage was extracted by using double distilled water and precipitated with ethanol. The precipitated mucilage was dried and grounded into powder. The tablet utilizing the mucilage as excipient was prepared by wet granulation method. The tablets were subjected to various tests. The evaluatory parameters of tablets were found to be within the limits as per United States Pharmacopoeia NF 24/19. FTIR spectrum reveals that there is no incompatibility between the ingredients used. Diabetes was induced in wistar albino rats using streptozotocin and effect of formulation on blood glucose level was determined. It was observed that the formulation could not sustain the release of glipizide. However, the glipizide release was retarded as the amount of mucilage was increased. It was observed that on the completion of antidiabetic study, the formulation could bring the blood glucose level to normal in group rats. However, the blood glucose level was still elevated in group administered with pure gliplizide. It can be concluded that HRM can be used to formulate glipizide tablets. The formulations with HRM shows better hypoglycemic activity and this may be attributed to antidiabetic activity of Hibiscus rosasinensis.

Keywords

Hibiscus rosasinensis, glipizide, mucilage, antidiabetic activity, excipients

Full Text:

PDF

References

Adzu, B., Zakariya, S. T., Auta, I. K., & Katsayal, U. A. Assessing the potency of Pedilanthus tithymaloides latex against Plasmodium berghei berghei infected mice. Int. J. Biol Chem Sci. 2008; 2(2), 216-219.

Alderton, W. K., Cooper, C. E., & Knowles, R. G. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001; 357(3), 593-615.

Baeuerle, P. A. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim. Biophys. Acta (BBA)-Reviews on Cancer 1991; 1072(1), 63-80.

Bogdan, C. Nitric oxide and the immune response. Nature Immunol. 2001; 2(10), 907-916.

Bouaboula, M., Hilairet, S., Marchand, J., Fajas, L., Le Fur, G., & Casellas, P. Anandamide induced PPARγ transcriptional activation and 3T3-L1 preadipocyte differentiation. Eur. J. Pharmacol. 2005; 517(3), 174-181.

Castaldo, S., & Capasso, F. Propolis, an old remedy used in modern medicine. Fitoterapia 2002; 73, S1-S6.

Choi, S. S., Cha, B. Y., Lee, Y. S., Yonezawa, T., Teruya, T., Nagai, K., & Woo, J. T. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells. Life Sci. 2009; 84(25), 908-914.

Dawn, B., & Bolli, R. Role of nitric oxide in myocardial preconditioning. Ann. N. Y. Acad. Sci. 2002; 962(1), 18-41.

Ghosh, C., Hong, B., Batabyal, S., Jeon, T. I., Yang, S. H., & Hwang, S. G. Anti-inflammatory activity of the ethanol extract of Dictamnus dasycarpus leaf in lipopolysaccharide-activated macrophages. BMC Complement Altern Med. 2014; 14(1), 330.

Hassan, M., El Yazidi, C., Landrier, J. F., Lairon, D., Margotat, A., & Amiot, M. J. Phloretin enhances adipocyte differentiation and adiponectin expression in 3T3-L1 cells. Biochem. Biophys. Res. Commun. 2007; 361(1), 208-213.

Heinrich, M., Rimpler, H., & Barrera, N. A. Indigenous phytotherapy of gastrointestinal disorders in a lowland Mixe community (Oaxaca, Mexico): Ethnopharmacologic evaluation. J. Ethnopharmacol. 1992; 36(1), 63-80.

Jain, S. K., & Srivastava, S. Traditional uses of some Indian plants among islanders of the Indian Ocean; 2005.

Joseph, B., & Priya, M. Review on nutritional, medicinal and pharmacological properties of guava (Psidium guajava Linn.). Int. J. Pharma Bio Sci. 2011; 2(1), 53-69.

Manaharan, T., Ming, C. H., & Palanisamy, U. D. (2013). Syzygium aqueum leaf extract and its bioactive compounds enhances pre-adipocyte differentiation and 2-NBDG uptake in 3T3-L1 cells. Food Chem. 2013; 136(2), 354-363.

Njamen, D., Talla, E., Mbafor, J. T., Fomum, Z. T., Kamanyi, A., Mbanya, J. C., ... & Rı́, J. L. Anti-inflammatory activity of erycristagallin, a pterocarpene from Erythrina mildbraedii. Eur. J. Pharmacol. 2003; 468(1), 67-74.

Oliveira, A. M. D., Conserva, L. M., de Souza Ferro, J. N., Brito, F. D. A., Lemos, R. P. L., & Barreto, E. Antinociceptive and anti-inflammatory effects of octacosanol from the leaves of Sabicea grisea var. grisea in mice. Int. J. Mol. Sci. 2012; 13(2), 1598-1611.

Park, E. J., Min, H. Y., Ahn, Y. H., Bae, C. M., Pyee, J. H., & Lee, S. K. Synthesis and inhibitory effects of pinosylvin derivatives on prostaglandin E 2 production in lipopolysaccharide-induced mouse macrophage cells. Bioorganic Med. Chem. Lett. 2004; 14(23), 5895-5898.

Rosen, E. D., Walkey, C. J., Puigserver, P., & Spiegelman, B. M. Transcriptional regulation of adipogenesis. Genes Dev. 2000; 14(11), 1293-1307.

Singh, L. W. Traditional medicinal plants of Manipur as anti-diabetics. J. Med. Plants Res. 2011; 5(5), 677-687.

Vergara, E. J. S., Dela Cruz, J., Kim, C. M., & Hwang, S. G. Increased adipocyte differentiation may be mediated by extracellular calcium levels through effects on calreticulin and peroxisome proliferator activated receptor gamma expression in intramuscular stromal vascular cells isolated from Hanwoo beef cattle. Ital J. Anim. Sci. 2016; 15(2), 256-263.

Winrow, C. J., Kassam, A., Miyata, K. S., Marcus, S. L., Hunter, J., Capone, J. P., & Rachubinski, R. A. Interplay of the Peroxisome Proliferator‐activated Receptor and the Thyroid Hormone Receptor‐signaling Pathways in Regulating Peroxisome Proliferator–responsive Genes. Ann. N. Y. Acad. Sci. 1996; 804(1), 214-230.

World Health Organization (2016). Prevalence data of diabetes in Philippines. Available from: URL: http://www.who.int/diabetes/country-profiles/phl_en.pdf?ua=1

DOI: http://dx.doi.org/10.14499/indonesianjpharm29iss1pp1